Oral Nirmatrelvir–Ritonavir for Covid-19 in Higher-Risk Outpatients
Butler et al., New England Journal of Medicine, doi:10.1056/NEJMoa2502457 (results released 9/10/2025)
https://c19early.org/butler7.html